BMO Capital

Analysts at BMO Capital downgraded Tenet Healthcare Corp. (NYSE: THC) from Outperform to Market Perform. The price target for Tenet Healthcare is set to $50. Tenet Healthcare shares have gained 16.74% over the past 52 weeks, while the S&P 500 index has surged 11.80% in the same period. Tenet...

Analysts at BMO Capital upgraded Chegg, Inc. (NYSE: CHGG) from Market Perform to Outperform. The price target for Chegg has been raised from $8.00 to $10.00. Chegg shares have gained 4.98% over the past 52 weeks, while the S&P 500 index has surged 14.34% in the same period. Chegg's shares rose...

Analysts at BMO Capital initiated coverage on Jazz Pharmaceuticals plc (NASDAQ: JAZZ) with a Outperform rating. The target price for Jazz Pharmaceuticals is set to $200. Jazz Pharmaceuticals shares have gained 0.45% over the past 52 weeks, while the S&P 500 index has surged 12.30% in the same...

After many volatile months in the oil industry, BMO Capital analyst Daniel Boyd is ready for an energy bounce back. In a note Tuesday, of the 18 energy stocks mentioned, Boyd listed 13 as either Outperform or Market Perform. For the U.S. oil services sector as a whole, he initiated the sector...

Analysts at BMO Capital initiated coverage on Schlumberger Limited (NYSE: SLB) with a Outperform rating. The target price for Schlumberger is set to $105. Schlumberger shares have dropped 1.76% over the past 52 weeks, while the S&P 500 index has surged 14.85% in the same period. Schlumberger's...

Analysts at BMO Capital downgraded Omnicom Group Inc. (NYSE: OMC) from Outperform to Market Perform. The price target for Omnicom has been lowered from $82.00 to $77.00. Omnicom shares have climbed 3.18% over the past 52 weeks, while the S&P 500 index has surged 13.71% in the same period....

BMO Capital upgraded Hasbro Inc. (NASDAQ: HAS) from Market Perform to Outperform. The price target for Hasbro has been raised from $55.00 to $70.00. Hasbro shares have climbed 13.92% over the past 52 weeks, while the S&P 500 index has surged 12.47% in the same period. Hasbro's shares jumped 0....

Analysts at BMO Capital initiated coverage on Post Holdings, Inc. (NYSE: POST) with a Outperform rating. The target price for Post Holdings is set to $56. Post Holdings shares have declined 11.03% over the past 52 weeks, while the S&P 500 index has surged 14.57% in the same period. Post...

Analysts at BMO Capital upgraded Pfizer Inc. (NYSE: PFE) from Market Perform to Outperform. The price target for Pfizer has been raised from $33 to $36. Pfizer shares have gained 5.40% over the past 52 weeks, while the S&P 500 index has surged 14.57% in the same period. Pfizer's shares fell 0....

Analysts at BMO Capital downgraded Dean Foods Company (NYSE: DF) from Outperform to Market Perform. The price target for Dean Foods has been lowered from $21 to $20. Dean Foods shares have surged 24.66% over the past 52 weeks, while the S&P 500 index has gained 15.35% in the same period. Dean...

BMO Capital upgraded Tenet Healthcare Corp. (NYSE: THC) from Market Perform to Outperform. The price target for Tenet Healthcare is set to $50. Tenet Healthcare shares have dropped 5.10% over the past 52 weeks, while the S&P 500 index has surged 15.14% in the same period. Tenet Healthcare's...

Analysts at BMO Capital upgraded Rock-Tenn Company (NYSE: RKT) from Market Perform to Outperform. Rock-Tenn shares have surged 29.92% over the past 52 weeks, while the S&P 500 index has gained 14.53% in the same period. Rock-Tenn's shares fell 0.87% to close at $64.90 on Friday.

Analysts at BMO Capital upgraded Boston Scientific Corporation (NYSE: BSX) from Market Perform to Outperform. The price target for Boston Scientific has been raised from $15.00 to $18.00. Boston Scientific shares have gained 9.76% over the past 52 weeks, while the S&P 500 index has surged 13.39...